NEW YORK Lifebit Biotech announced Thursday that it had been awarded a four-year contract by the Danish National Genome Center (NGC). This contract will support Denmark’s national personalized medicines strategy. The contract’s amount was not disclosed by the company.
The London-based bioinformatics firm will use its Lifebit CloudOS software on the NGC’s supercomputing core to create a federated system. Trusted research environmentfor data management and analysis. In its first phase, the program will sequence the genomes from 60,000 patients suffering from cancer, autoimmune disorders, or rare diseases by 2024.
“This federated trusted researcher environment will enable researchers more effectively collaborate over the rich dataset at scale, and drive international cooperation between other government initiatives,”Thorben Seeger said in a statement.
The company has already partnered with other European biobanks, including Genomics England and France Gnomique, Genomic Medicine Sweden and the Hong Kong Genome Institute.
